Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Secondary Prophylaxis of CMV Infection Using Letermovir After HID-HSCT [Phase 4]
Phase 4 trial exploring secondary prophylaxis of CMV reactivation with letermovir after HID-HSCT; efficacy and safety being evaluated.